Acute human immunodeficiency virus replication causes a rapid and persistent impairment of Vγ9Vδ2 T cells in chronically infected patients undergoing structured treatment interruption

被引:39
作者
Martini, F [1 ]
Poccia, F [1 ]
Goletti, D [1 ]
Carrara, S [1 ]
Vincenti, D [1 ]
D'Offizi, G [1 ]
Agrati, C [1 ]
Ippolito, G [1 ]
Colizzi, V [1 ]
Pucillo, LP [1 ]
Montesano, C [1 ]
机构
[1] Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Clin Pathol Lab, Int Ctr AIDS & Emerging Infect, I-00149 Rome, Italy
关键词
D O I
10.1086/342410
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T cells expressing Vgamma9Vdelta2 display lytic and proliferative responses against human immunodeficiency virus (HIV)-infected cells and release antiviral soluble factors. Chronic HIV-positive patients have deep changes in the composition and function of the circulating gammadelta T cell pool that are restored by highly active antiretroviral therapy (HAART). gammadelta T cells were analyzed during the rapid plasma HIV RNA rebound in HIV-infected patients undergoing structured treatment interruption (STI). A loss in circulating Vgamma9Vdelta2 T cells was observed, indicating that acute HIV replication may influence Vgamma9Vdelta2 homeostasis. These cells were lost among CD45RA(-)CD27(-) Vgamma9Vdelta2 T cell effectors, and a significant unresponsiveness, measured as antigen-driven interferon-gamma production, was observed during STI. After HAART resumption and consequent inhibition of HIV replication, Vgamma9Vdelta2 T cell reactivity was restored both quantitatively and functionally. These observations indicate that Vgamma9Vdelta2 T cells are activated early after active HIV replication but are rapidly lost when viremia is not controlled.
引用
收藏
页码:847 / 850
页数:4
相关论文
共 15 条
[1]   Functional inactivation in the whole population of human V gamma 9/V delta 2 T lymphocytes induced by a nonpeptidic antagonist [J].
Burk, MR ;
Carena, I ;
Donda, A ;
Mariani, F ;
Mori, L ;
DeLibero, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (01) :91-97
[2]   Lack of CD27-CD45RA-Vγ9Vδ2+ T cell effectors in immunocompromised hosts and during active pulmonary tuberculosis [J].
Gioia, C ;
Agrati, C ;
Casetti, R ;
Cairo, C ;
Borsellino, G ;
Battistini, L ;
Mancino, G ;
Goletti, D ;
Colizzi, V ;
Pucillo, LP ;
Poccia, F .
JOURNAL OF IMMUNOLOGY, 2002, 168 (03) :1484-1489
[3]  
JANSSEN O, 1991, J IMMUNOL, V146, P35
[4]   Control of HIV despite the discontinuation of antiretroviral therapy [J].
Lisziewicz, J ;
Rosenberg, E ;
Lieberman, J ;
Jessen, H ;
Lopalco, L ;
Siliciano, R ;
Walker, B ;
Lori, F .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (21) :1683-1684
[5]  
LUNDGREN JD, 2002, 9 C RETR OPP INF SEA, P70
[6]   γδ T-cell anergy in human immunodeficiency virus-infected persons with opportunistic infections and recovery after highly active antiretroviral therapy [J].
Martini, F ;
Urso, R ;
Gioia, C ;
De Felici, A ;
Narciso, P ;
Amendola, A ;
Paglia, MG ;
Colizzi, V ;
Poccia, F .
IMMUNOLOGY, 2000, 100 (04) :481-486
[7]   Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects [J].
Ortiz, GM ;
Wellons, M ;
Brancato, J ;
Vo, HTT ;
Zinn, RL ;
Clarkson, DE ;
Van Loon, K ;
Bonhoeffer, S ;
Miralles, GD ;
Montefiori, D ;
Bartlett, JA ;
Nixon, DF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (23) :13288-13293
[8]   EVIDENCE FOR EXTRATHYMIC CHANGES IN THE T-CELL RECEPTOR-GAMMA-DELTA REPERTOIRE [J].
PARKER, CM ;
GROH, V ;
BAND, H ;
PORCELLI, SA ;
MORITA, C ;
FABBI, M ;
GLASS, D ;
STROMINGER, JL ;
BRENNER, MB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (05) :1597-1612
[9]   Phosphoantigen-reactive Vγ9Vδ2 T lymphocytes suppress in vitro human immunodeficiency virus type 1 replication by cell-released antiviral factors including CC chemokines [J].
Poccia, F ;
Battistini, L ;
Cipriani, B ;
Mancino, G ;
Martini, F ;
Gougeon, ML ;
Colizzi, V .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (03) :858-861
[10]   Innate T-cell immunity to nonpeptidic antigens [J].
Poccia, F ;
Gougeon, ML ;
Bonneville, M ;
Lôpez-Botet, M ;
Moretta, A ;
Battistini, L ;
Wallace, M ;
Colizzi, V ;
Malkovsky, M .
IMMUNOLOGY TODAY, 1998, 19 (06) :253-256